SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec Lifesciences gets nod to raise Rs 50 crore via NCDs

31 Jan 2023 Evaluate

Astec Lifesciences’ board has approved the proposal to raise funds through issuance of Non-Convertible Debentures (NCD) for expansion and development of business operations of the Company and meeting the short term and long-term financial requirements of the Company, including but not limited to, expenditure proposed to be incurred for improving the facilities being provided in its set-up and / or meeting the working capital requirements, for an amount upto Rs 50 crore. The Board of Directors of the Company, at its Meeting held on January 30, 2023 has approved the same.

Astec Lifesciences manufactures a wide range of agrochemicals and pharmaceutical intermediates.

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×